The Patent Finder

Immunovative Therapies, Ltd.

Also on record
Records under this name other than patents Immunovative Therapies, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Immunovative Therapies, Ltd.

PatentTitleStatus Expires Confidence
US 8,865,224Allogeneic cellular immunotherapy for opportunistic infection
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,272,001Ablative immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,320,794Ablative immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,160,852Method of vaccinating using allogeneic cells
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,972,594Ablative immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,751,372Vaccine compositions and methods
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,744,158Th1 vaccination priming for active immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,695,397Th1 vaccination priming for active immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,385,315Cells expressing Th1 characteristics and cytolytic properties
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,233,156Induction of IL-12 using immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 43 patents shown.
Pro members see all 43.
Pro members: see all 43 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited